Cite
MLA Citation
CJ Edwards et al.. “FRI0487 Apremilast is associated with long-term (4-YEAR) DAS-28 (CRP) remission and improvements in skin disease: results from a phase iii study in dmard/biologic-experienced patients with active psoriatic arthritis.” Annals of the rheumatic diseases, vol. 76, n.d., p. 672. http://access.bl.uk/ark:/81055/vdc_100135147264.0x00005c